MO-John, with all due respect, I take issue with many of the things you espouse. The fact of the matter is they "are" a small company at this point but they don't expect to be one in the future. Therefore, audited financials and such are a hit to the bottom line. Small companies don't tend to have millions in the bank (yet) so you have to choose wisely where to spend. Not sure if you ever ran your own business but if you did this point would hit big with you.
As for the: "clearly many NNLX shareholders are happy with little or no communication but then do something idiotic like calling Battelle..."
<I am not sure how you can draw an accurate assumption that it is indeed a happy shareholder or even a shareholder at this point>
In a prior post you allude to the footnote section as being the most important part of the financials at this stage of the game for this company. And you would like to know if there are any royalties or revenues the company has to pay out. I know that one of the main methods of cash raising was through PIPES. Technically speaking the company cannot directly solicit a PIPE so it is easier said than done. Furthermore, in conversations with the company in the past I learned that the company does not entertain situations where they would freely compensate others in stock or percentages of ownership of the company for marketing value. Therefore, when they eventually come out with the financials I strongly believe you will be satisfied with the footnote section and lack of nefarious info you think might possibly be revealed there.
As a happy long, I am comforted with the most recent website release of the intention to proceed with the FDA submissions. If you know what this company was before Barnhizer took over you would be elated that he has taken this company this far. If not for him, this would be just another lost investment. If you got in at higher prices than today's PPS I believe patience will prove wise as the few P.R.s that are released do hint at very promising revenues. And what we are talking about here is a plastic petri dish which cost pennies, a membrane (cheap in bulk) some agar and labor and other operating costs. Massed produced in an already built manufacturing facility I believe the gross profit margins will exceed 50 percent at first. So that leaves it to revenue. How much revenue can this company produce. Based on the fact it is essentially a model of a time proven and successful existing product with a lot more bells and whistles (faster), I believe with the recent third party validation and the pending FDA approvals, likelihood of immense revenues appear good. So in essence, with good revenues and solid profit margins, NNLX has a great base to build a successful and long enduring company upon.
Patience.
News 
Market Data 
Discover 
AI
